Annovis Bio Inc. (ANVS) Social Stream



Annovis Bio Inc. (ANVS): $18.92

-1.16 (-5.78%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ANNOVIS BIO INC (ANVS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ANVS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-22 1 $70 $70 $70 $16.52 323.73%
2022-04-08 1 $26 $26 $26 $16.52 57.38%
2022-08-09 2 $37 $26 $31.5 $16.52 90.68%
2023-01-30 3 $72 $26 $46 $16.52 178.45%

The Trend in the Analyst Price Target


ANVS's average price target has moved up $20 over the prior 42 weeks.

Over the past 42 weeks, ANVS's average upside potential has been 171.41%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-08 1 26 26 26.0 12.17 113.64%
2022-05-02 2 37 26 31.5 9.96 216.27%
2022-05-05 2 37 26 31.5 11.25 180%
2022-08-09 2 37 26 31.5 12.01 162.28%
2022-09-14 3 72 26 46.0 20.28 126.82%

ANVS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 29 months, ANVS's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ANVS as an investment opportunity.

  • In terms of how ANNOVIS BIO INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 15.7% of that group.
  • ANNOVIS BIO INC's variance in analysts' estimates is lower than 7.62% of Pharmaceutical Products stocks.
  • ANNOVIS BIO INC's average analyst price target is higher than 387.12% of stocks in the small market cap category.
  • In the context of Pharmaceutical Products stocks, ANNOVIS BIO INC's upside potential (average analyst target price relative to current price) is higher than 222.53% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ANNOVIS BIO INC are LMNL, ETNB, and GRTX.

What is the outlook for ANVS? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6115 seconds.